
Cardinal Health, Inc.
Cardinal Health, Inc. is a United States-based company in the Healthcare sector with a market capitalisation of $58.8B. Its FinScore is 69/100; its highest-scoring layer is Momentum (90) and its lowest is Growth (44). The shares trade at 34.3x trailing earnings and are up 23% year to date.
Share price performance
About Cardinal Health, Inc.
www.cardinalhealth.comCardinal Health, Inc. operates as a global, integrated provider of healthcare services and products, with its reach spanning the United States, Canada, Europe, Asia, and other international markets. The company delivers bespoke support to a diverse clientele, including hospitals, healthcare networks, pharmacies, outpatient surgical centers, clinical labs, physician practices, and individuals receiving care at home. It is structured into two core divisions: Pharmaceutical and Medical. The Pharmaceutical division oversees the distribution of a wide array of products, encompassing branded, generic, and specialty pharmaceuticals, along with over-the-counter health and consumer goods. This segment additionally offers specialized services to pharmaceutical manufacturers and healthcare providers, particularly for specialty pharmaceutical products. Its operations extend to managing nuclear pharmacies and facilities that produce radiopharmaceuticals. It also performs repackaging of generic drugs and OTC items. Further offerings include medication therapy management and patient outcomes services for hospitals, other healthcare providers, and payers, in addition to providing pharmacy management solutions to hospitals. The Medical division focuses on producing, sourcing, and supplying Cardinal Health-branded medical, surgical, and laboratory products and devices. This extensive product range encompasses items such as examination and surgical gloves, needles, syringes, sharps disposal units, compression products, incontinence aids, nutritional delivery systems, wound care supplies, single-use drapes, gowns, and apparel, fluid suction and collection devices, urological products, operating room essentials, and electrodes. Beyond its proprietary brands, this segment also distributes various national brand medical, surgical, and laboratory products. It offers comprehensive supply chain management for hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare organizations, and manufactures and sells both sterile and non-sterile procedure kits. Established in 1979, the company maintains its headquarters in Dublin, Ohio.
- Sector
- Healthcare
- Industry
- Medical - Distribution
- HQ
- United States
- Fiscal year-end
- June
- Trading currency
- USD
- Reporting currency
- USD
- Fundamentals updated
- 67 days ago
- Market cap
- $58.8B
- Shares outstanding
- 231.6M
- P/E (TTM)
- 34.3x
- Dividend yield (TTM)
- 0.81%
- Beta (issuer)
- 0.50
- Revenue (latest FY)
- $254.2B
Revenue breakdown
- Pharmaceutical Member92.3%$234.8B
- GMPD5.0%$12.7B
- Other Operating Segment2.7%$6.8B
FinScore
As of 2026-10-19Snapshot
Ownership
As of 2026-06-30Sign up or log in to see Analysis
Analysis for Cardinal Health, Inc. is available to Finryse members. The Overview stays open to everyone; creating an account is free.
Sign up or log in to see Financials
Financials for Cardinal Health, Inc. is available to Finryse members. The Overview stays open to everyone; creating an account is free.
Sign up or log in to see Estimates
Estimates for Cardinal Health, Inc. is available to Finryse members. The Overview stays open to everyone; creating an account is free.
Sign up or log in to see Peers
Peers for Cardinal Health, Inc. is available to Finryse members. The Overview stays open to everyone; creating an account is free.
Sign up or log in to see Valuation
Valuation for Cardinal Health, Inc. is available to Finryse members. The Overview stays open to everyone; creating an account is free.
Sign up or log in to see News
News for Cardinal Health, Inc. is available to Finryse members. The Overview stays open to everyone; creating an account is free.